CDH1 and invasive ductal breast carcinoma: Interestingly, the latest studies have demonstrated that E-cadherin functions as an invasion suppressor and survival factor in breast invasive ductal carcinoma, which is the most common type of breast cancer (Dossus and Benusiglio, 2015; Padmanaban et al., 2019).